Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High-risk Melanoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT01274338
What this trial is testing

Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery

Who this might be right for
Melanoma of Unknown PrimaryRecurrent MelanomaStage IIIB Cutaneous Melanoma AJCC v7+2 more
National Cancer Institute (NCI) 1,673
Testing effectiveness (Phase 2)Study completedNCT00003568
What this trial is testing

Vaccine Therapy With High-Dose Interleukin-2 in Treating Patients With Metastatic Melanoma

Who this might be right for
Melanoma (Skin)
University of Illinois at Chicago
Not applicableLooking for participantsNCT05053555
What this trial is testing

High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies

Who this might be right for
Liver Malignant TumorsCholangiocarcinoma MetastaticPancreatic Cancer+1 more
M.D. Anderson Cancer Center 60
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Large-scale testing (Phase 3)Ended earlyNCT05665595
What this trial is testing

Adjuvant Pembrolizumab/Vibostolimab (MK-7684A) Versus Pembrolizumab for Resected High-Risk Melanoma in Participants With High-Risk Stage II-IV Melanoma (MK-7684A-010/KEYVIBE-010)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 1,594
Early research (Phase 1)Study completedNCT01996202
What this trial is testing

A Pilot Study of Ipilumimab and Radiation in Poor Prognosis Melanoma

Who this might be right for
High Risk Melanoma
Duke University 24
Not applicableStudy completedNCT00184275
What this trial is testing

Characterization of Brain Metastases

Who this might be right for
Neoplasm MetastasisLung NeoplasmsBreast Neoplasms+1 more
Norwegian University of Science and Technology 26
Testing effectiveness (Phase 2)Study completedNCT00565721
What this trial is testing

A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis

Who this might be right for
High-grade GliomaLung CancerHead & Neck Cancer+2 more
GE Healthcare 33
Large-scale testing (Phase 3)Study completedNCT00006237
What this trial is testing

S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma

Who this might be right for
Melanoma (Skin)
SWOG Cancer Research Network 432
Early research (Phase 1)Study completedNCT02020707
What this trial is testing

Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers

Who this might be right for
Cervical AdenocarcinomaCervical AdenosarcomaCervical Adenosquamous Carcinoma+45 more
Mayo Clinic 43
Large-scale testing (Phase 3)Study completedNCT00636168
What this trial is testing

Efficacy Study of Ipilimumab Versus Placebo to Prevent Recurrence After Complete Resection of High Risk Stage III Melanoma

Who this might be right for
High Risk Stage III Melanoma
Bristol-Myers Squibb 1,211
Testing effectiveness (Phase 2)Study completedNCT01118091
What this trial is testing

Prospective Randomized Comparative Study of Cell Transfer Therapy Using CD8+-Enriched Short-Term Cultured Anti-Tumor Autologous Lymphocytes Following a Non-Myeloablative Lymphocyte Depleting Chemotherapy Regimen Compared to High-Dose Aldesleukin in M...

Who this might be right for
Skin CancerMelanomaMetastatic Melanoma
National Cancer Institute (NCI) 12
Early research (Phase 1)Study completedNCT00304460
What this trial is testing

Mechanism of Action of High-Dose IL-2 (Aldesleukin) in Metastatic Melanoma and Kidney Cancer

Who this might be right for
Metastatic MelanomaRenal Cell Cancer
National Cancer Institute (NCI) 138
Not applicableStudy completedNCT03457766
What this trial is testing

Presurgical Evaluation of Skin Cancers Using HIFU

Who this might be right for
Skin Cancer, Non-Melanoma
Assiut University 40
Not applicableNot Yet RecruitingNCT07645742
What this trial is testing

Pilot Study of Intermittent Fasting With Immune Checkpoint Inhibitors

Who this might be right for
Cancer (Advanced Stage)
West Virginia University 90
Testing effectiveness (Phase 2)Study completedNCT00462280
What this trial is testing

Lovastatin in Treating Patients At High Risk of Melanoma

Who this might be right for
Precancerous ConditionStage 0 MelanomaStage I Melanoma+1 more
National Cancer Institute (NCI) 80
Early research (Phase 1)Looking for participantsNCT06889766
What this trial is testing

NY-ESO-1-redirected T Cells in Patients With Advanced Melanoma and Sarcoma

Who this might be right for
Advanced MelanomaMelanoma MetastaticSarcoma
Centre Hospitalier Universitaire Vaudois 9
Large-scale testing (Phase 3)Ended earlyNCT04410445
What this trial is testing

Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence

Who this might be right for
MelanomaMelanoma Stage IIIMelanoma Stage IV+1 more
Nektar Therapeutics 765
Very early researchWithdrawnNCT03022565
What this trial is testing

Vorinostat in Patients With Class 2 High Risk Uveal Melanoma

Who this might be right for
Uveal Melanoma
University of Miami
Testing effectiveness (Phase 2)Study completedNCT00273910
What this trial is testing

Evaluation of the Impact of Adjuvants Accompanying Peptide Immunization in High-Risk Melanoma

Who this might be right for
High-Risk Melanoma
National Cancer Institute (NCI) 104
Next Page